Home › NDC Lookup › RxCUI directory › RxCUI 2360548

2.8 ML octreotide 2.5 MG/ML Pen Injector [Bynfezia] — RxCUI 2360548

RxNorm drug concept · Semantic branded drug
RxCUI 2360548 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2360548
Official name2.8 ML octreotide 2.5 MG/ML Pen Injector [Bynfezia]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asBynfezia 2.5 MG/ML per 2.8 ML Pen Injector; Bynfezia 2500 MCG/ML in 2.8 ML Pen Injector; Bynfezia 2500 MCG/ML per 2.8 ML Pen Injector
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Octreotide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Octreotide works like a more powerful version of a natural hormone in your body called somatostatin. Depending on what it's prescribed for, it either lowers your growth hormone lev...
  • What exactly does octreotide do — and why do I need it?
  • Yes, timing around food matters a lot with Mycapssa. You need to take it on a completely empty stomach — at least one hour before you eat anything, or at least two hours after your...
  • How do I take Mycapssa correctly — does it matter if I eat first?
📖 Read our full Octreotide guide →

🕸️ Concept Web — How 2.8 ML octreotide 2.5 MG/ML Pen Injector [Bynfez... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 2.8 ML octreotide 2.5 MG/ML Pen Injector [Bynfezia] RxCUI 2360548

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Octreotide 7617
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Bynfezia 2360544
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Octreotide Pen Injector 2360542
    • Octreotide Injectable Product 1160449
    • Octreotide Pen Injector [Bynfezia] 2360546
    • Bynfezia Injectable Product 2360547
    • Pen Injector 1649571
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Octreotide 2.5 MG/ML [Bynfezia] SBDC · 2360545
  • Octreotide Pen Injector [Bynfezia] SBDF · 2360546
  • Bynfezia Injectable Product SBDG · 2360547
  • Bynfezia BN · 2360544

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2360548 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
62756-0452-36 1 CARTRIDGE in 1 CARTON (62756-452-36) / 2.8 mL in 1 CARTRI... BYNFEZIA Pen Sun Pharmaceutical Industries, Inc. 2025-02-24
62756-0452-37 2 CARTRIDGE in 1 CARTON (62756-452-37) / 2.8 mL in 1 CARTRI... BYNFEZIA Pen Sun Pharmaceutical Industries, Inc. 2025-02-24
Observed labelers: Sun Pharmaceutical Industries, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.